Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.

By Hallqvist Andreas   Rylander Hillevi   Björk-Eriksson Thomas   Nyman Jan  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 969-974

Informa Healthcare

Access to resources Recommend Favorite

Induction and concurrent chemotherapy with concomitant boost radiotherapy in non-small cell lung cancer

By Oral Ethem   Aydiner Adnan   Eralp Yeşim   Topuz Erkan  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 367-374

Humana Press, Inc

Access to resources Recommend Favorite

Rapidly Alternating Combination of Cisplatin-based Chemotherapy and Hyperfractionated Accelerated Radiotherapy in Split Course for Stage IIIA and Stage IIIB Non-small Cell Lung Cancer: Results of a Phase I-II Study by the GOTHA Group

By Alberto P.   Mirimanoff R.O.   Mermillod B.   Leyvraz S.   Nagy-Mignotte H.   Bolla M.   Wellmann D.   Moro D.   Brambilla E.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 342-348

Elsevier

Access to resources Recommend Favorite

Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy

By              

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 1017-1022

Spandidos Publications

Access to resources Recommend Favorite

Chemotherapy: still an essential player in non-small-cell lung cancer treatment?

By Ferreira Carlos Gil   Montella Tatiane Caldas   Baldotto Clarissa Seródio   Domingues Pedro Masson  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 381-390

Future Medicine

Access to resources Recommend Favorite